Cargando…

Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia

Cerebral hypoxia-ischemia (HI) compromises the proteasome in a clinically relevant neonatal piglet model. Protecting and activating proteasomes could be an adjunct therapy to hypothermia. We investigated whether chymotrypsin-like proteasome activity differs regionally and developmentally in the neon...

Descripción completa

Detalles Bibliográficos
Autores principales: El Demerdash, Nagat, Chen, May W., O’Brien, Caitlin E., Adams, Shawn, Kulikowicz, Ewa, Martin, Lee J., Lee, Jennifer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391411/
https://www.ncbi.nlm.nih.gov/pubmed/34440889
http://dx.doi.org/10.3390/cells10082120
_version_ 1783743268466458624
author El Demerdash, Nagat
Chen, May W.
O’Brien, Caitlin E.
Adams, Shawn
Kulikowicz, Ewa
Martin, Lee J.
Lee, Jennifer K.
author_facet El Demerdash, Nagat
Chen, May W.
O’Brien, Caitlin E.
Adams, Shawn
Kulikowicz, Ewa
Martin, Lee J.
Lee, Jennifer K.
author_sort El Demerdash, Nagat
collection PubMed
description Cerebral hypoxia-ischemia (HI) compromises the proteasome in a clinically relevant neonatal piglet model. Protecting and activating proteasomes could be an adjunct therapy to hypothermia. We investigated whether chymotrypsin-like proteasome activity differs regionally and developmentally in the neonatal brain. We also tested whether neonatal brain proteasomes can be modulated by oleuropein, an experimental pleiotropic neuroprotective drug, or by targeting a proteasome subunit gene using recombinant adeno-associated virus-9 (AAV). During post-HI hypothermia, we treated piglets with oleuropein, used AAV-short hairpin RNA (shRNA) to knock down proteasome activator 28γ (PA28γ), or enforced PA28γ using AAV-PA28γ with green fluorescent protein (GFP). Neonatal neocortex and subcortical white matter had greater proteasome activity than did liver and kidney. Neonatal white matter had higher proteasome activity than did juvenile white matter. Lower arterial pH 1 h after HI correlated with greater subsequent cortical proteasome activity. With increasing brain homogenate protein input into the assay, the initial proteasome activity increased only among shams, whereas HI increased total kinetic proteasome activity. OLE increased the initial neocortical proteasome activity after hypothermia. AAV drove GFP expression, and white matter PA28γ levels correlated with proteasome activity and subunit levels. However, AAV proteasome modulation varied. Thus, neonatal neocortical proteasomes can be pharmacologically activated. HI slows the initial proteasome performance, but then augments ongoing catalytic activity. AAV-mediated genetic manipulation in the piglet brain holds promise, though proteasome gene targeting requires further development.
format Online
Article
Text
id pubmed-8391411
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83914112021-08-28 Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia El Demerdash, Nagat Chen, May W. O’Brien, Caitlin E. Adams, Shawn Kulikowicz, Ewa Martin, Lee J. Lee, Jennifer K. Cells Article Cerebral hypoxia-ischemia (HI) compromises the proteasome in a clinically relevant neonatal piglet model. Protecting and activating proteasomes could be an adjunct therapy to hypothermia. We investigated whether chymotrypsin-like proteasome activity differs regionally and developmentally in the neonatal brain. We also tested whether neonatal brain proteasomes can be modulated by oleuropein, an experimental pleiotropic neuroprotective drug, or by targeting a proteasome subunit gene using recombinant adeno-associated virus-9 (AAV). During post-HI hypothermia, we treated piglets with oleuropein, used AAV-short hairpin RNA (shRNA) to knock down proteasome activator 28γ (PA28γ), or enforced PA28γ using AAV-PA28γ with green fluorescent protein (GFP). Neonatal neocortex and subcortical white matter had greater proteasome activity than did liver and kidney. Neonatal white matter had higher proteasome activity than did juvenile white matter. Lower arterial pH 1 h after HI correlated with greater subsequent cortical proteasome activity. With increasing brain homogenate protein input into the assay, the initial proteasome activity increased only among shams, whereas HI increased total kinetic proteasome activity. OLE increased the initial neocortical proteasome activity after hypothermia. AAV drove GFP expression, and white matter PA28γ levels correlated with proteasome activity and subunit levels. However, AAV proteasome modulation varied. Thus, neonatal neocortical proteasomes can be pharmacologically activated. HI slows the initial proteasome performance, but then augments ongoing catalytic activity. AAV-mediated genetic manipulation in the piglet brain holds promise, though proteasome gene targeting requires further development. MDPI 2021-08-18 /pmc/articles/PMC8391411/ /pubmed/34440889 http://dx.doi.org/10.3390/cells10082120 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
El Demerdash, Nagat
Chen, May W.
O’Brien, Caitlin E.
Adams, Shawn
Kulikowicz, Ewa
Martin, Lee J.
Lee, Jennifer K.
Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia
title Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia
title_full Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia
title_fullStr Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia
title_full_unstemmed Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia
title_short Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia
title_sort oleuropein activates neonatal neocortical proteasomes, but proteasome gene targeting by aav9 is variable in a clinically relevant piglet model of brain hypoxia-ischemia and hypothermia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391411/
https://www.ncbi.nlm.nih.gov/pubmed/34440889
http://dx.doi.org/10.3390/cells10082120
work_keys_str_mv AT eldemerdashnagat oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia
AT chenmayw oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia
AT obriencaitline oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia
AT adamsshawn oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia
AT kulikowiczewa oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia
AT martinleej oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia
AT leejenniferk oleuropeinactivatesneonatalneocorticalproteasomesbutproteasomegenetargetingbyaav9isvariableinaclinicallyrelevantpigletmodelofbrainhypoxiaischemiaandhypothermia